AstraZeneca Seals $1.26 Billion Ardea Deal

AstraZeneca Seals $1.26 Billion Ardea Deal: U.K. drug maker AstraZeneca is buying U.S.-based Ardea Biosciences for $1.26 billion, a deal that will expand its thin pipeline of new medicines.

Comments

Post a Comment